MiMedx Group Inc (MDXG) Financial Statements (2024 and earlier)

Company Profile

Business Address 1775 W OAK COMMONS COURT, NE
MARIETTA, GA 30062
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments82,00065,95087,08395,81269,06945,118
Cash and cash equivalents82,00065,95087,08395,81269,06945,118
Receivables53,87143,78841,09645,46832,345454
Inventory, net of allowances, customer advances and progress billings21,02113,18311,38910,3619,10415,986
Inventory21,02113,18311,38910,3619,10415,986
Prepaid expense5,6248,6466,1465,6056,6696,673
Other current assets1,7452,6312,8093,3716,0585,818
Total current assets:164,261134,198148,523160,617123,24574,049
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization 5198145  
Operating lease, right-of-use asset2,1323,4004,6963,6233,397
Property, plant and equipment    11,43712,32817,424
Intangible assets, net (including goodwill)24,69825,82825,35925,98027,75329,584
Goodwill19,44119,97619,97619,97619,97619,976
Intangible assets, net (excluding goodwill)5,2575,8525,3836,0047,7779,608
Deferred income tax assets40,777    
Other noncurrent assets2051481863754431,787
Other undisclosed noncurrent assets6,9237,7589,020   
Total noncurrent assets:74,78637,23239,40641,41543,92148,795
TOTAL ASSETS:239,047171,430187,929202,032167,166122,844
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities18,40919,87140,79257,69253,46354,866
Employee-related liabilities23,59518,46721,30223,024
Accounts payable9,0488,8477,3858,765  
Accrued liabilities9,36111,0249,81230,46032,16131,842
Debt5349  3,750 
Disposal group, including discontinued operation1,352     
Other liabilities3,8941,8341,5651,4701,3991,817
Other undisclosed current liabilities22,30021,803  8,71014,864
Total current liabilities:46,00843,55742,35759,16267,32271,547
Noncurrent Liabilities
Long-term debt and lease obligation48,09948,59448,12747,69761,906 
Long-term debt, excluding current maturities48,09948,59448,12747,69761,906 
Liabilities, other than long-term debt2,2234,7734,8693,7553,5401,642
Other liabilities2,2234,7734,8693,7553,5401,642
Total noncurrent liabilities:50,32253,36752,99651,45265,4461,642
Total liabilities:96,33096,92495,353110,614132,76873,189
Temporary equity, carrying amount  92,49492,49491,568  
Equity
Equity, attributable to parent142,717(17,988)82(150)34,39849,655
Common stock146114113113113113
Treasury stock, value   (4,017)(7,449)(10,806)(38,642)
Additional paid in capital276,249173,804165,695158,610147,231164,744
Accumulated deficit(133,678)(191,906)(161,709)(151,424)(102,140)(76,560)
Total equity:142,717(17,988)82(150)34,39849,655
TOTAL LIABILITIES AND EQUITY:239,047171,430187,929202,032167,166122,844

Income Statement (P&L) ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues321,477267,841258,615248,234299,255359,111
Cost of revenue
(Cost of Goods and Services Sold)
(54,634)(48,316)(43,283)(39,330)(43,081)(36,386)
Gross profit:266,843219,525215,332208,904256,174322,725
Operating expenses(224,551)(232,319)(216,523)(193,810)(210,830)(275,327)
Other undisclosed operating loss(5,176)(12,177)(3,844)(60,492)(66,504)(51,322)
Operating income (loss):37,116(24,971)(5,035)(45,398)(21,160)(3,924)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(26)(4)(23)(3)283527
Interest and debt expense(7)(10)(13)(8,201)(6,650) 
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes   (7,941)1,942 
Income (loss) from continuing operations before equity method investments, income taxes:37,083(24,985)(5,071)(61,543)(25,585)(3,397)
Other undisclosed loss from continuing operations before income taxes(6,450)(5,006)(4,967)   
Income (loss) from continuing operations before income taxes:30,633(29,991)(10,038)(61,543)(25,585)(3,397)
Income tax expense (benefit)36,806(206)(247)12,2595(26,582)
Income (loss) from continuing operations:67,439(30,197)(10,285)(49,284)(25,580)(29,979)
Loss before gain (loss) on sale of properties:(10,285)(49,284)(25,580)(29,979)
Net income (loss):67,439(30,197)(10,285)(49,284)(25,580)(29,979)
Other undisclosed net loss attributable to parent(9,211)     
Net income (loss) attributable to parent:58,228(30,197)(10,285)(49,284)(25,580)(29,979)
Preferred stock dividends and other adjustments(11,643)(6,580)    
Other undisclosed net loss available to common stockholders, basic   (6,136)(34,044)  
Net income (loss) available to common stockholders, basic:46,585(36,777)(16,421)(83,328)(25,580)(29,979)
Convertible preferred dividends6,466     
Dilutive securities, effect on basic earnings per share 6,466     
Other undisclosed net income available to common stockholders, diluted      
Net income (loss) available to common stockholders, diluted:59,517(36,777)(16,421)(83,328)(25,580)(29,979)

Comprehensive Income ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net income (loss):67,439(30,197)(10,285)(49,284)(25,580)(29,979)
Comprehensive income (loss), net of tax, attributable to parent:67,439(30,197)(10,285)(49,284)(25,580)(29,979)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: